Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYHX1901 in Moderate to Severe Plaque Psoriasis
NCT05858047Phase 2Completed
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Apr 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SYHX-1901 in plaque psoriasis, sponsored by CSPC Ouyi Pharmaceutical. Started Apr 2023; status: completed.
02
Drugs
SYHX-1901
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05858047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05858047.